Advertisement

Topics

Molecular Targeting Technologies, Inc. and Medical College of Wisconsin Company Profile

18:00 EST 10th December 2018 | BioPortfolio


News Articles [2503 Associated News Articles listed on BioPortfolio]

Babyscripts program, Wisconsin health network announce partnership

Physicians at the Froedtert & Medical College of Wisconsin (MCW), in Milwaukee, Wisconsin, will now have access to a mobile tool that monitors patients' progress during pregnancy.

Molecular Targeting Technologies, Inc. Wins Exclusive License for Novel Neuroendocrine Neoplasm ...

Molecular Targeting Technologies, Inc.Chris Pak, 610-738-7938cpak@mtarget.comorInvestorsJianwei Xu, 856-428-8168Jxu@mtarget.com Read more...

MCG lab designated to help with patient testing for NCI-MATCH trial

(Medical College of Georgia at Augusta University) The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory fo...

MCG selected as designated laboratory for NCI-MATCH trial

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysi...

Leading Prenatal App, Babyscripts, Partners with Froedtert & the Medical College of Wisconsin Health Network

MILWAUKEE (PRWEB) October 03, 2018 Babyscripts , the leading prenatal app and the first mobile clinical tool to allow OB/GYNs to re...

NorthStar Medical Technologies appoints new president, CEO

NorthStar Medical Technologies, the Beloit, Wisconsin-based parent company of NorthStar Medical Radioisotopes, has appointed Stephen Merrick as president and CEO. Merrick was first hired in 2016 as...

BioForward Announces Winners of Fourth Annual Wisconsin Biohealth Awards

BioForward has announced the winners of the annual Wisconsin Biohealth Awards, dedicated to showcasing leadership and innovation in the Wisconsin biohealth industry. The 2018 winn...

After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield

Wisconsin’s biggest startup investment in recent memory didn’t end up happening, but now the two companies involved appear to be on the verge of striking a potentially larger deal. Shine M...

PubMed Articles [5012 Associated PubMed Articles listed on BioPortfolio]

Wisconsin Health Care Making Progress Toward CMS Quality Strategy Goals.

Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology: Introduction to the Program and Summary of 2016 Geographic Variation.

Antimicrobial resistance merits surveillance because of its impact on quality health care. Past surveillance efforts in Wisconsin involved generation of a statewide antibiogram on the basis of antibio...

Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.

The Medical Technologies Evaluation Programme (MTEP) of NICE in England aims to evaluate medical devices that are deemed to be cost-saving or cost-neutral and produce Medical Technology Guidance (MTG)...

First Detection of Aedes albopictus (Diptera: Culicidae) and Expansion of Aedes japonicus japonicus in Wisconsin, United States.

The 2015-2016 epidemic of Zika virus in the Americas raised concerns about the range of Aedes albopictus (Skuse) in the United States. In response, the University of Wisconsin Medical Entomology Labor...

CRISPR-Based Technologies: Impact of RNA-Targeting Systems.

DNA-targeting CRISPR-Cas systems, such as those employing the RNA-guided Cas9 or Cas12 endonucleases, have revolutionized our ability to predictably edit genomes and control gene expression. Here, I s...

Clinical Trials [4789 Associated Clinical Trials listed on BioPortfolio]

IMPLEMENTATION OF MOLECULAR DIAGNOSTIC PATHWAYS

Most neurological and neurodegenerative diseases have a multifactorial nature. For some of them it is documented a genetic component (sometimes described as Mendelian, other times as a mul...

Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia

This is a prospective phase II clinical study to be conducted at the Medical College of Wisconsin. After meeting the study criteria and enrollment, patients will be treated with CLAG-M che...

Survey for Usage Rates of Pertussis Vaccines in the State of Wisconsin

The purpose of this study is to determine during the course of 5 years, the patterns of pertussis vaccine usage by brand and dose among children birth through 59 months of age who have rec...

Long-term Follow-up Study of Patients Receiving CAR-20/19-T Cells

This protocol is designed as a long-term follow-up study of patients who will receive genetically modified autologous CAR-T cells as part of clinical trial at the Medical College of Wiscon...

Helping College Students With ADHD Lead Healthier Lifestyles

There are currently no published randomized controlled studies examining psychosocial interventions for college students with ADHD, and none specifically targeting AUDs in this population ...

Companies [4710 Associated Companies listed on BioPortfolio]

Molecular Targeting Technologies, Inc. and Medical College of Wisconsin

Molecular Targeting Technologies, Inc.

Molecular Targeting Technologies, Inc. (MTTI) is a privately held US based Biotechnology Company founded to develop novel medical imaging products for the diagnosis of cardiovascu...

Medical College of Wisconsin

ProtoPROBE, Inc.

ProtoPROBE Incorporated is a privately owned and operated s-corporation with office and laboratories located in the Technology Innovation Center, Milwaukee County Research Park, Milwaukee, Wisconsin. ...

Prodesse, Inc

Prodesse, Inc., a biotechnology firm based near Milwaukee, Wisconsin, was founded to commercialize a novel, patented methodology first developed by researchers at the Medical College of Wisconsin and ...

More Information about "Molecular Targeting Technologies, Inc. and Medical College of Wisconsin" on BioPortfolio

We have published hundreds of Molecular Targeting Technologies, Inc. and Medical College of Wisconsin news stories on BioPortfolio along with dozens of Molecular Targeting Technologies, Inc. and Medical College of Wisconsin Clinical Trials and PubMed Articles about Molecular Targeting Technologies, Inc. and Medical College of Wisconsin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Targeting Technologies, Inc. and Medical College of Wisconsin Companies in our database. You can also find out about relevant Molecular Targeting Technologies, Inc. and Medical College of Wisconsin Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record